Pharma distribution directory 2026

    Pharmaceutical Distributors in Morocco

    Morocco runs one of the most regulated wholesale systems in Africa: 66 licensed grossistes-répartiteurs, each obliged to hold safety stock and serve every pharmacy in its territory, deliver about 70% of the medicines dispensed by the country’s 12,000-plus independent pharmacies at margins fixed by decree.

    Because pharmacy ownership is reserved for individual pharmacists and chains are prohibited, the wholesaler is the only route to retail scale, and the Competition Council reported in 2026 that six groups control 84% of a wholesale market worth MAD 16.3 billion. Manufacturers, whether Moroccan companies such as Cooper Pharma, Sothema and Laprophan or multinational affiliates, sell to these wholesalers and directly to the Ministry of Health, which buys through its procurement division for public hospitals and the expanding AMO insurance population. The new Agence Marocaine des Médicaments et des Produits de Santé (AMMPS) has taken over registration and establishment licensing from the former Direction du Médicament. This directory lists the public buyer, the leading wholesale groups by region and the manufacturer-distributors that shape access to Moroccan pharmacies and clinics.

    Updated September 2026 · Agence Marocaine des Médicaments et des Produits de Santé (AMMPS) — établissements pharmaceutiques grossistes-répartiteurs register as of September 2026 · 16 named accounts

    Request a proposal for MoroccoBrowse the 16 companies

    MAD 16.3bn

    Wholesale distribution turnover, 2024 (Competition Council)

    66

    Licensed grossistes-répartiteurs in activity, 2024

    84%

    Wholesale market share held by the six largest groups

    ~70%

    Share of pharmacy-dispensed medicines routed via wholesalers

    Named accounts

    Top pharmaceutical distributors in Morocco

    Public, well-known names BioNixus studies at account and SKU level. This is an editorial snapshot, not an endorsement or a market-share ranking. Cross-checked against Agence Marocaine des Médicaments et des Produits de Santé (AMMPS) — établissements pharmaceutiques grossistes-répartiteurs register (as of 2026-09-03).
    #CompanyHQ
    01Ministry of Health and Social Protection — Division de l’ApprovisionnementRabat
    02Cooper Pharma RépartitionCasablanca
    03SophacaCasablanca
    04GPM (Groupement Pharmaceutique du Maroc)Casablanca
    05UGP (Union des Grossistes Pharmaceutiques)Casablanca
    06DipharmCasablanca
    07SPR (Société de Pharmacie et de Répartition)Casablanca
    08RecamedCasablanca
    09SophadimCasablanca
    10Afric Med DistributionCasablanca
    11Oriental MedicaOujda
    12C.P.R.E (Coopérative Pharmaceutique de Répartition de l’Est)Oujda
    13Maphar (Eurapharma / CFAO)Casablanca
    14SothemaBouskoura
    15LaprophanCasablanca
    16DHL Global Forwarding MarocCasablanca

    Primary research

    These are the distributors and wholesalers we map in Morocco

    Choosing or auditing a distribution partner in Morocco? BioNixus runs distributor due-diligence interviews, channel-share estimates and pharmacy-level availability checks. Proposal ready within 48 hours of a brief.

    Planning research in Morocco?

    Primary research, market access & HEOR. A 30-minute scoping call, then a costed proposal within 48 hours.

    What happens on the call

    • We pin down the decision your research has to support.
    • We check feasibility: respondent types, countries and timeline.
    • You receive a costed proposal within 48 hours of the call.

    Top market research companies in Morocco (2026)

    How the market is structured

    How pharmaceutical distribution works in Morocco

    A medicine reaches a Moroccan patient through one of two chains. In the private chain, the industrial pharmaceutical establishment holding the marketing authorisation, either a local manufacturer or the Moroccan affiliate of a multinational, sells to grossistes-répartiteurs, which deliver several times a day to independent pharmacies and to the medicine reserves of private clinics. Wholesaler and pharmacy margins are set by the 2014 pricing reform: roughly 10% of the public price for the wholesaler on standard products, falling to under 2% on high-priced specialty lines, which is why wholesalers compete on delivery frequency, credit and regional depth rather than price. The big groups operate regional subsidiaries, so Cooper Pharma Répartition, for example, covers the Casablanca-Settat, Chaouia and Tensift regions through separate entities, while Oriental Medica and C.P.R.E serve the east from Oujda. In the public chain, the Ministry of Health’s procurement division tenders nationally for hospitals and health centres, and the roll-out of AMO Tadamon insurance for previously uncovered households is shifting demand from cash purchases to reimbursed prescriptions. Casablanca-Settat and Rabat-Salé-Kénitra host 39% of the wholesalers; coverage of the south and the interior depends on a handful of regional operators and on the safety-stock obligations imposed on every licensee.

    Local

    Moroccan grossistes-répartiteurs licensed by AMMPS to buy from manufacturers and deliver to every pharmacy and clinic in their territory under safety-stock and public-service obligations.

    • Cooper Pharma Répartition
    • Sophaca
    • GPM (Groupement Pharmaceutique du Maroc)
    • UGP (Union des Grossistes Pharmaceutiques)
    • Dipharm
    • SPR (Société de Pharmacie et de Répartition)
    • Recamed
    • Sophadim
    • Afric Med Distribution
    • Oriental Medica
    • C.P.R.E (Coopérative Pharmaceutique de Répartition de l’Est)
    • Sothema
    • Laprophan

    Multinational

    Foreign-owned distribution platforms and freight providers; Maphar imports and distributes for multinational principals, while logistics groups move temperature-sensitive product into Casablanca and Tangier.

    • Maphar (Eurapharma / CFAO)
    • DHL Global Forwarding Maroc

    Regional

    Maghreb and pan-African groups that use Morocco as a base for West African supply, reflecting the country’s ambition to become a pharmaceutical export hub.

    Wholesalers, importers & 3PL

    The Ministry of Health procurement division and the listed and family-owned manufacturers whose direct tender sales and wholesaler terms shape access to Moroccan patients.

    • Ministry of Health and Social Protection — Division de l’Approvisionnement

    What is moving

    What is moving pharma distribution in Morocco

    Generalisation of health insurance (AMO Tadamon)

    Extending compulsory insurance to previously uncovered households is converting out-of-pocket purchases into reimbursed prescriptions, lifting pharmacy volumes and rewarding wholesalers with rural reach.

    Competition Council review of distribution

    The 2026 opinion on pharmaceutical distribution questions the 84% concentration among six groups and the regulated margin structure, opening the door to reforms in pricing, pharmacy capital and wholesaler obligations.

    Local manufacturing and export hub strategy

    Government support for local production of biosimilars, vaccines and generics, plus Morocco’s trade links to West Africa, is pushing wholesalers to add export and re-export capabilities.

    Margin pressure and consolidation

    With net margins near 1% and operating costs up 36% since 2020, independent wholesalers are merging or joining groups, and service differentiation increasingly depends on logistics automation.

    BioNixus fieldwork

    How BioNixus studies pharmaceutical distributors in Morocco

    The accounts above are the ones our field teams and analysts work with. What a brand team typically commissions from us in Morocco:
    • Wholesaler service benchmarking: 40–80 pharmacist interviews across Casablanca, Rabat, Marrakech, Fès, Tangier and Oujda rating delivery frequency, credit, returns and stock-out handling by grossiste.
    • Share-of-wholesaler estimates by region from pharmacy purchase-record audits of defined chronic and OTC baskets.
    • Ministry of Health tender landscaping: bidders, award prices and the split between local manufacturers and multinational affiliates.
    • Private clinic purchasing studies covering formulary decisions and direct-from-manufacturer versus wholesaler supply.

    Questions

    Frequently Asked Questions

    Can a foreign pharmaceutical company distribute directly in Morocco?

    It must operate through a licensed industrial pharmaceutical establishment, either its own Moroccan affiliate or a local partner, that holds the marketing authorisation. That establishment then sells to grossistes-répartiteurs and to public tenders; direct sales to pharmacies are not part of the model.

    Why are there no pharmacy chains in Morocco?

    Moroccan law reserves pharmacy ownership to individual pharmacists and prohibits multi-store ownership. The Competition Council has recommended opening pharmacy capital, but until that changes, wholesalers remain the only route to national retail coverage.

    How concentrated is pharmaceutical wholesale in Morocco?

    Highly. Although 66 wholesalers hold licences, the Competition Council found that six groups control 84% of wholesale turnover and three of them account for nearly 65%, largely through regional subsidiaries.

    What margins do Moroccan wholesalers earn?

    Margins are fixed by regulation: about 11% on the purchase price for medicines with a manufacturer price up to MAD 588, and 2% above that threshold. Average net profitability across the sector is around 1%, which explains the pressure to consolidate.

    What does BioNixus study about pharmaceutical distributors in Morocco?

    Wholesaler service benchmarking through pharmacist interviews in Casablanca, Rabat, Marrakech, Fès and Oujda; share-of-wholesaler estimates from pharmacy purchase records; Ministry of Health tender mapping; and clinic purchasing studies as private hospital capacity grows.

    Are the wholesalers here ordered by market share?

    No. The directory groups participants by function and includes those that recur in BioNixus Moroccan fieldwork and on the AMMPS establishment register; position in the list does not reflect turnover.

    Sources

    Data sources & methodology

    This directory aggregates publicly available company and channel facts — filings, brand sites, and BioNixus fieldwork in Morocco. It is an editorial snapshot of the accounts we study, not a share ranking and not a substitute for NielsenIQ, IQVIA, or another syndicated feed.

    Primary register: Agence Marocaine des Médicaments et des Produits de Santé (AMMPS) — établissements pharmaceutiques grossistes-répartiteurs register, consulted 2026-09-03. Company classification (Local / MNC / Regional / wholesalers, importers & 3pl) reflects ownership and role in Morocco, not size.

    • Conseil de la Concurrence opinion on pharmaceutical distribution markets, published March 2026 (via Médias24 coverage)
    • Casablanca Stock Exchange filings for Sothema and Cooper Pharma group disclosures, 2024–2025
    • Ministry of Health and Social Protection procurement notices and AMO Tadamon rollout updates, 2024–2026
    • BioNixus Morocco pharmacy and clinic fieldwork, 2023–2026

    BioNixus sells account-level and SKU-level primary research that complements those subscriptions. For a scoped proposal, contact the team or use the form below. Email admin@bionixus.com.

    48-hour proposal

    Need distributor and channel data in Morocco?

    Coverage, credit terms, cold-chain capability and share of pharmacy purchases by wholesaler — from the pharmacies and hospitals themselves, not a directory.

    Planning research in Morocco?

    Primary research, market access & HEOR. A 30-minute scoping call, then a costed proposal within 48 hours.

    What happens on the call

    • We pin down the decision your research has to support.
    • We check feasibility: respondent types, countries and timeline.
    • You receive a costed proposal within 48 hours of the call.